Processa Pharmaceuticals PCSA
NASDAQ PCSA
$2.07 -0.08 (-3.76%)
As of: Aug 21, 2026 · 3:59 PM EDT

Processa Pharmaceuticals (PCSA) Net Margin Growth (1y) (2013 - 2016)

Processa Pharmaceuticals (PCSA) Net Margin Growth (1y) (2013 - 2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -763.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 529.00
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4,168.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 673.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 2,208.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -1,652.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 29,636.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -392.00
10 Processa Pharmaceuticals 5.69 Mn 5.69 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2016 -88,662.00
Dec 31, 2015 1.77 Mn
Sep 30, 2015 -8,572.00
Jun 30, 2015 -910,362.00
Mar 31, 2015 871,958.00
Dec 31, 2014 -1.92 Mn
Sep 30, 2014 -91,614.00
Jun 30, 2014 -39,503.00
Mar 31, 2014 -595,234.00
Dec 31, 2013 213,219.00
Sep 30, 2013 66,905.00
Jun 30, 2013 -22,843.00